Published in J Clin Lipidol on December 01, 2009
Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms | NCT00332644
High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol (2012) 3.11
Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart J (2014) 1.57
Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J (2011) 1.50
Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. Am Heart J (2010) 1.10
Long-term effects of smoking and smoking cessation on exercise stress testing: three-year outcomes from a randomized clinical trial. Am Heart J (2011) 0.95
Analysis of factors that determine weight gain during smoking cessation therapy. PLoS One (2013) 0.91
The effect of chronic tobacco smoking and chewing on the lipid profile. J Clin Diagn Res (2013) 0.90
Triglyceride-based screening tests fail to recognize cardiometabolic disease in African immigrant and African-American men. Metab Syndr Relat Disord (2012) 0.89
Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial. J Dual Diagn (2013) 0.85
High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction. PLoS One (2013) 0.83
Association of the ST3GAL4 rs11220462 polymorphism and serum lipid levels in the Mulao and Han populations. Lipids Health Dis (2014) 0.79
Number of components of the metabolic syndrome; smoking and inflammatory markers. Int J Endocrinol Metab (2012) 0.77
E-cigarettes induce toxicological effects that can raise the cancer risk. Sci Rep (2017) 0.75
Serum CETP and PLTP activity in middle-aged men living in urban or rural area of the Lower Silesia region. PURE Poland sub-study. Arch Med Sci (2016) 0.75
Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk. Arterioscler Thromb Vasc Biol (2016) 0.75
Effect of Cigarette Smoking on Haematological Parameters in Healthy Population. Med Arch (2017) 0.75
Ambient and at-the-ear occupational noise exposure and serum lipid levels. Int Arch Occup Environ Health (2016) 0.75
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc (2003) 47.83
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol (2004) 6.44
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet (2006) 5.85
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med (2006) 4.91
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
High-density lipoprotein as a therapeutic target: a systematic review. JAMA (2007) 3.92
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2008) 3.15
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (1989) 2.96
Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women--without associated overall health benefit. Atherosclerosis (2006) 2.38
Cigarette smoking and the risk of diabetes in women. Am J Public Health (1993) 1.95
Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis (2008) 1.92
Interventions to reduce harm from continued tobacco use. Cochrane Database Syst Rev (2007) 1.87
Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. Nicotine Tob Res (2006) 1.55
Low HDL-C: a secondary target of dyslipidemia therapy. Am J Med (2005) 1.55
Clearing the smoke: the science base for tobacco harm reduction--executive summary. Tob Control (2001) 1.53
Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J (2004) 1.41
Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis (2006) 1.38
Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther (2005) 1.33
Harm reduction. BMJ (2004) 1.27
The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol (2002) 1.26
LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol (1999) 1.16
Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation (1980) 1.11
Factors associated with lipoprotein cholesterol levels. The Framingham study. Arteriosclerosis (1983) 1.06
Harm-reduction approaches to smoking. The need for data. Am J Prev Med (1998) 1.00
Obesity and smoking: comparing cessation treatment seekers with the general smoking population. Obesity (Silver Spring) (2009) 0.95
Should advanced lipoprotein testing be used in clinical practice? Nat Clin Pract Cardiovasc Med (2006) 0.84
Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev (2004) 9.30
Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54
American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr (2004) 4.88
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry (2009) 4.66
A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol (2004) 4.24
Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health (2004) 3.71
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care (2008) 3.65
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol (2008) 3.36
Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: a randomized, controlled trial. J Natl Cancer Inst (2004) 3.26
A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet (2008) 3.25
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2008) 3.15
Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation (2007) 2.82
Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med (2005) 2.80
Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res (2006) 2.77
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Prevalence and predictors of transitions in smoking behavior among college students. Health Psychol (2004) 2.64
Have we lost our way? The need for dynamic formulations of smoking relapse proneness. Addiction (2002) 2.48
New methods for tobacco dependence treatment research. Ann Behav Med (2011) 2.44
The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med (2011) 2.43
Does detection of carotid plaque affect physician behavior or motivate patients? Am Heart J (2007) 2.33
Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol (2006) 2.30
Prospective study of particulate air pollution exposures, subclinical atherosclerosis, and clinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air). Am J Epidemiol (2012) 2.23
Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol (2002) 2.18
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation (2008) 2.17
Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest (2002) 2.02
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry (2012) 2.02
Smoking cessation via the internet: a randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention. Nicotine Tob Res (2006) 2.02
Clinical practice. Treating smokers in the health care setting. N Engl J Med (2011) 1.99
Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med (2009) 1.95
Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol (2008) 1.86
Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res (2009) 1.84
Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol (2003) 1.79
Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J Abnorm Psychol (2008) 1.72
A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. Nicotine Tob Res (2008) 1.70
Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol (2003) 1.64
Development of the Brief Wisconsin Inventory of Smoking Dependence Motives. Nicotine Tob Res (2010) 1.63
Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res (2008) 1.62
Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol (2010) 1.61
Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol (2010) 1.60
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction (2010) 1.60
Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl) (2011) 1.60
Smoking-cessation media campaigns and their effectiveness among socioeconomically advantaged and disadvantaged populations. Am J Public Health (2008) 1.57
A pilot study on mindfulness based stress reduction for smokers. BMC Complement Altern Med (2007) 1.55
Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction (2008) 1.53
The role of health care systems in increased tobacco cessation. Annu Rev Public Health (2008) 1.53
Life 1 year after a quit attempt: real-time reports of quitters and continuing smokers. Ann Behav Med (2012) 1.52
Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol (2005) 1.50
Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J (2011) 1.50
Smoker characteristics and smoking-cessation milestones. Am J Prev Med (2011) 1.47
Cardiovascular risks of antiretroviral therapy. N Engl J Med (2007) 1.45
Advanced lipoprotein testing does not improve identification of subclinical atherosclerosis in young adults: the Bogalusa Heart Study. Ann Intern Med (2005) 1.44
A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One (2012) 1.44
Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. JAMA Psychiatry (2013) 1.38
Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. Stroke (2007) 1.38